Tags |
|
|
Links |
|
|
E-Articles - Weight Loss Drugs
Weight loss drugs might sound like the easy option to take to lose weight. But you should consider other methods before using weight loss drugs. Th
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
e best way of losing weight is the natural way - through dieting and exercise. However, some people struggle to lose weight. They do all the right
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
hings, but the weight does not come off.
If you are one of these people, then you might consider weight loss drugs to help achieve a clinical sign
If you are one of these people, then you might consider weight loss drugs to help achieve a clinical sign
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ficant weight loss. Weight loss drugs are not meant to be used by the Jacks and Jills who just want to lose a few pounds for cosmetic reasons. You
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
an benefit from weight loss drugs if you are obese, and this obesity is causing health problems.
Weight-loss drugs should not replace the need for
Weight-loss drugs should not replace the need for
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
changes in your eating habits or activity level.
Practitioners may recommend weight loss drugs to different classes of people including:
Practitioners may recommend weight loss drugs to different classes of people including:
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
atients with a body mass index (BMI) of 30 or more,
Overweight patients with a BMI of 27 or more who either lack "good" HDL cholesterol,
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ave too much "bad" LDL cholesterol, are at risk of developing type 2 diabetes, have a high blood pressure, or have sleep apnea
People who
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
have tried other weight loss methods, and failed
Common drugs available on the market
Some commonly available drugs ar
Common drugs available on the market
Some commonly available drugs ar
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
listed below. This list is by no means exhaustive. The first two are available on the NHS, if you meet their criteria.
- Sibutramine (Me
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
idia (US) /Reductil (UK)). This drug changes your brain chemistry, making you feel full more quickly. Typical dosage is 10 milligrams (mg) once
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
a day. Possible side-effects include increased blood pressure, headache, dry mouth, constipation and insomnia.
Orlistat (Xenical).
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
Prevents the absorption of fat in your intestines. Normal dosage is 120 mg three times a day. Possible side effects include frequent oily bowel mov
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ments, diarrhea, bloating and abdominal pain.
Rimonabant (Acomplia). Works by blocking the endocannabinoid system in the brain whi
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
h regulates hunger. This stifles hunger and cravings. You take 1 pill a day. Possible side effects include dizziness, nausea, anxiety, diarrhea and
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
insomnia.
During tests sibutramine and orlistat users typically achieved weight losses of 3-4 percent over a year. Rimonabant users typi
During tests sibutramine and orlistat users typically achieved weight losses of 3-4 percent over a year. Rimonabant users typi
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ally achieved 5-10%, with almost 40% achieving 10% weight loss. Rimonabant is not expected to be on the NHS within the next two years due to its co
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
t (?55 per patient per month).
The downside to weight loss drugs
Once you start taking a weight-loss drug, you'll likely need to
The downside to weight loss drugs
Once you start taking a weight-loss drug, you'll likely need to
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
take it indefinitely. When you stop drug treatment, however, much or all of the lost weight generally returns, unless you have changed your lifesty
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
e.
The dilemma with taking the drugs indefinitely is that the most common weight-loss drugs are so new that possible long-term effects are unknown
The dilemma with taking the drugs indefinitely is that the most common weight-loss drugs are so new that possible long-term effects are unknown
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/261419/e-article-Weight-Loss-Drugs.html">Weight Loss Drugs</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/261419/e-article-Weight-Loss-Drugs.html]Weight Loss Drugs[/url]
Related Articles:
When, Why, and How to Use Mailing Lists
Powerful Protection for Your Health with Thyme Oil - Kills Virus & Bacteria
Vitamin Supplement to Treat Hair Loss: Zinc
Bookmark it:
|